Truvestments Capital LLC Amgen Inc Transaction History

Truvestments Capital LLC

$363 Million
Q3 2024

A detailed history of Truvestments Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Truvestments Capital LLC holds 722 shares of AMGN stock, worth $204,766. This represents 0.06% of its overall portfolio holdings.

Number of Shares

722

Previous 1,713 57.85%

Holding current value

$204,766

Previous $535,000 56.64%

% of portfolio

0.06%

Previous 0.22%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $306,595 - $334,343	-991 Reduced 57.85%	722 $232,000
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $157,912 - $191,905	601 Added 54.05%	1,713 $535,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $3,764 - $4,543	14 Added 1.28%	1,112 $316,000
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $280,758 - $316,729	1,098 New	1,098 $316,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $916 - $1,164	4 New	4 $1,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $12,846 - $14,252	-55 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $1,877 - $2,087	-8 Reduced 12.7%	55 $14,000
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $11,481 - $15,227	63 New	63 $12,000
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $6,054 - $7,782	-32 Closed	0 $0
Q3 2019 Oct 10, 2019	SELL	$174.11 - $208.62 $16,888 - $20,236	-97 Reduced 75.19%	32 $6,000
Q2 2019 Jul 15, 2019	SELL	$166.7 - $195.41 $20,504 - $24,035	-123 Reduced 48.81%	129 $24,000
Q1 2019 Apr 12, 2019	BUY	$180.87 - $203.88 $361 - $407	2 Added 0.8%	252 $48,000
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $46,322 - $52,222	250 New	250 $52,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.

Account

Truvestments Capital LLC Amgen Inc Transaction History